Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Other 13Gastrointestinal 12Lymphoid 3Thoracic 2Other hematologic neoplasm 2Head & Neck 2Gynecologic 2Genitourinary 2Endocrine 2Dermatologic 2Classical hematology 2Breast 2Other solid neoplasm 1Myeloid 1

Conditions

Prostatic Neoplasms 1216Urinary Bladder Neoplasms 387Carcinoma, Renal Cell 329Kidney Neoplasms 205Neoplasms 157Breast Neoplasms 146Lung Neoplasms 101Carcinoma, Transitional Cell 100Colorectal Neoplasms 77Testicular Neoplasms 74Ovarian Neoplasms 62Melanoma 60Pancreatic Neoplasms 57Colonic Neoplasms 50Carcinoma, Non-Small-Cell Lung 50Head and Neck Neoplasms 47Disease 47Stomach Neoplasms 45Non-Muscle Invasive Bladder Neoplasms 45Neoplasm Metastasis 41Liver Neoplasms 40Uterine Cervical Neoplasms 39Esophageal Neoplasms 37Wilms Tumor 36Prostatic Hyperplasia 36Adenocarcinoma 33Multiple Myeloma 32Urologic Neoplasms 30Sarcoma 30Recurrence 30

Interventions

Pioglitazone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Diabetes Mellitus, Type 2 × Genitourinary × Clear all
NCT01935466 2022-01-25

PROBE-PIO

Post Graduate Institute of Medical Education and Research, Chandigarh

Completed
6,107 enrolled
Genitourinary

Urinary Bladder Neoplasms, Diabetes Mellitus, Type 2

NCT00782366 2011-04-27

PGT

Mayo Clinic

Completed
26 enrolled
BreastGastrointestinalGenitourinaryOtherThoracic

Atrial Fibrillation, Breast Neoplasms, Celiac Disease, Colonic Neoplasms, Diabetes Mellitus, Type 2, Graves Disease, Lung Neoplasms, Myocardial Infarction, Obesity, Osteoarthritis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡